Consensus Cybin Inc. OTC Markets

Equities

CLXP.F

CA23256X1006

End-of-day quote OTC Markets Other stock markets 18:00:00 2021-08-31 EDT			5-day change	1st Jan Change
2.63 ^CAD	-6.07%		+17.41%	+76.51%

04-17	Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	MT
04-16	Cybin Secures US Patent for CYB003 Program in Major Depressive Disorder Treatment	MT

Evolution of the average Target Price on Cybin Inc.

Price target over the last 5 years

History of analyst recommendation changes

efe41222636561f6145795be1.eAJDNXi4HRD9YbJdDlK8h0g964-EGnTbbVOiPzbNJJk.CWMqew78S1O-U8UnYAPzxgV5jvzpTzuBBRjoSESZUd82aycCPshZe7QVgg~d6450f5f2cda3214f028b216292dfe62

Analyst Recommendations on Cybin Inc.

HC Wainwright Adjusts Cybin Price Target to $5 From $10, Maintains Buy Rating	11-17	MT
Oppenheimer Adjusts Cybin Price Target to $4 From $4.50, Maintains Outperform Rating	23-08-15	MT
Canaccord Genuity Adjusts Price Target on Cybin to $5 From $6, Maintains Buy Rating	23-08-11	MT
Stifel Nicolaus Adjusts Cybin's Price Target to $1.13 From $1.10, Maintains Speculative Buy Rating	23-07-03	MT
Canaccord Genuity Trims Price Target on Cybin to $6 From $7, Maintains Buy Rating	23-07-03	MT
EF Hutton Initiates Cybin at Buy With $3 Price Target	22-12-16	MT
Stifel Nicolaus Adjusts Cybin Price Target to CA$3 From CA$8.25, Maintains Speculative Buy Rating	22-08-24	MT
Stifel Nicolaus Adjusts Cybin PT to CA$8.25 From CA$10, Maintains Speculative Buy Rating	21-11-23	MT
HC Wainwright Adjusts Cybin's Price Target to $10 From $8, Reiterates Buy Rating	21-11-22	MT
CYBIN : Oppenheimer Initiates Coverage on Cybin With Outperform Rating, $7 Price Target	21-10-05	MT
CYBIN : Canaccord Genuity Adjusts Cybin's Price Target to $7 From $6, Reiterates Buy Rating	21-08-27	MT
CYBIN : Cantor Fitzgerald Starts Cybin at Overweight with $9 Price Target	21-08-26	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.4789 CAD

Average target price

6.075 CAD

Spread / Average Target

+1,168.47%

High Price Target

8.083 CAD

Spread / Highest target

+1,587.75%

Low Price Target

4.105 CAD

Spread / Lowest Target

+757.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cybin Inc.

HC Wainwright
Oppenheimer
Canaccord Genuity
Stifel Nicolaus
EF Hutton
Cantor Fitzgerald

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar